The president's public remarks, to a certain extent, have become a key signal for the market to predict the future policy direction. Recently, under a series of internal and external pressures, Trump has sent out signals of détente. Let's continue to pay attention to more capital market dynamics.​

The number of Chinese concept stocks listing in the U.S. has been active, with continuous growth in both industry distribution and the quantity of listed companies. It is expected that the U.S. stock market will maintain a strong upward trend in the coming months.

When choosing a listing place, enterprises need to comprehensively consider their own industry attributes, development stage, capital planning and listing needs.

As of February 28, a total of 10 Chinese mainland companies have successfully landed on NASDAQ, covering intelligent machinery, biomedicine, environmental protection technology, intelligent parking and other fields. With its international market environment, efficient listing process and flexible capital operation mode, NASDAQ provides an attractive capital market platform for listed enterprises.

Enterprises planning to list in the United States must strengthen their compliance awareness and gain an in-depth understanding of the rules of the US stock market to avoid listing risks.

On February 20,2025, Mr.Yu Jung-mao, Executive Director of KP Health Technology, Mr.Yang Junhu, director, Representative Director of PARK JAESANG DS INDUS and Mr.Li Jin-hao, executive Director of E 2 BIO subsidiary of Ewha University, visited AGBA & SME Asia Pacific headquarters for a friendly visit and in-depth cooperation and exchange.

Nasdaq announced a blockbuster proposal to change the IPO rules, which has been approved by the board and is currently pending review by the Securities and Exchange Commission (SEC).

At the beginning of 2025, the capital market is active, and the SPAC model is still an important way for enterprises to go public